SERF VT Study Presented as Part of HRS 2020 Science Late-Breaking Clinical Trial Sessions

The SERF VT EFS is underway in the U.S. at Mayo Clinic, Loyola University Medical Center, and Vanderbilt University Medical Center, and in Canada at Southlake Regional Health Centre, Montreal Heart Institute and Quebec Heart and Lung Institute.

Thermedical Announces FDA IDE Approval to Begin US Clinical Study of Durablate Catheter for Treatment of Ventricular Tachycardia

7/31/18: Michael Curley, Ph.D., FHRS, co-founder and chief executive officer of Thermedical reported, “Receiving IDE approval to begin clinical testing of our innovative ablation therapy in patients is an important next step to advance treatment to reduce or potentially eliminate VT episodes."